Signalling Research Centres BIOSS and CIBSS, University of Freiburg, 79104, Freiburg, Germany.
Institute of Biology II, Faculty of Biology, University of Freiburg, 79104, Freiburg, Germany.
Nat Commun. 2019 Oct 31;10(1):4967. doi: 10.1038/s41467-019-12911-1.
To build or dissect complex pathways in bacteria and mammalian cells, it is often necessary to recur to at least two plasmids, for instance harboring orthogonal inducible promoters. Here we present SiMPl, a method based on rationally designed split enzymes and intein-mediated protein trans-splicing, allowing the selection of cells carrying two plasmids with a single antibiotic. We show that, compared to the traditional method based on two antibiotics, SiMPl increases the production of the antimicrobial non-ribosomal peptide indigoidine and the non-proteinogenic aromatic amino acid para-amino-L-phenylalanine from bacteria. Using a human T cell line, we employ SiMPl to obtain a highly pure population of cells double positive for the two chains of the T cell receptor, TCRα and TCRβ, using a single antibiotic. SiMPl has profound implications for metabolic engineering and for constructing complex synthetic circuits in bacteria and mammalian cells.
要在细菌和哺乳动物细胞中构建或剖析复杂的途径,通常至少需要使用两个质粒,例如,携带正交诱导启动子的质粒。这里我们介绍了 SiMPl,这是一种基于合理设计的分裂酶和内含子介导的蛋白质转剪接的方法,允许用单一抗生素选择携带两个质粒的细胞。我们表明,与基于两种抗生素的传统方法相比,SiMPl 提高了抗菌非核糖体肽靛蓝和非蛋白芳香族氨基酸对氨基-L-苯丙氨酸的产量,从细菌。我们使用人类 T 细胞系,使用 SiMPl 用单一抗生素获得了 TCRα和 TCRβ两条链双阳性的高度纯 T 细胞受体(TCR)的细胞群体。SiMPl 对代谢工程和在细菌和哺乳动物细胞中构建复杂的合成回路具有深远的意义。